Recombinant multi-species DDX3/DDX3X protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX3/DDX3X protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the large DEAD-box protein family, that is defined by the presence of the conserved Asp-Glu-Ala-Asp (DEAD) motif, and has ATP-dependent RNA helicase activity. This protein has been reported to display a high level of RNA-independent ATPase activity, and unlike most DEAD-box helicases, the ATPase activity is thought to be stimulated by both RNA and DNA. This protein has multiple conserved domains and is thought to play roles in both the nucleus and cytoplasm. Nuclear roles include transcriptional regulation, mRNP assembly, pre-mRNA splicing, and mRNA export. In the cytoplasm, this protein is thought to be involved in translation, cellular signaling, and viral replication. Misregulation of this gene has been implicated in tumorigenesis. This gene has a paralog located in the nonrecombining region of the Y chromosome. Pseudogenes sharing similarity to both this gene and the DDX3Y paralog are found on chromosome 4 and the X chromosome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]
The Alternative Names of target: ATP-dependent RNA helicase DDX3X,CAP-Rf,D1Pas1-rs2,DBX,DDX14,DDX3,DDX3X,DDX3Y,DEAD box,DEAD box protein 3,Ddx3,Ddx3x,Fin14,HLP2,Helicase-like protein 2 (HLP2),MRX102,MRXSSB,X isoform (DBX),X-chromosomal
Go
to DDX3/DDX3X products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP6119-Ag-1/ GM-Tg-hg-IP6119-Ag-2 | Human DDX3/DDX3X protein | Human |
| GM-Tg-rg-IP6119-Ag-1/ GM-Tg-rg-IP6119-Ag-2 | Rat DDX3/DDX3X protein | Rat |
| GM-Tg-mg-IP6119-Ag-1/ GM-Tg-mg-IP6119-Ag-2 | Mouse DDX3/DDX3X protein | Mouse |
| GM-Tg-cynog-IP6119-Ag-1/ GM-Tg-cynog-IP6119-Ag-2 | Cynomolgus/Rhesus macaque DDX3/DDX3X protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP6119-Ag-1/ GM-Tg-felg-IP6119-Ag-2 | Feline DDX3/DDX3X protein | Feline |
| GM-Tg-cang-IP6119-Ag-1/ GM-Tg-cang-IP6119-Ag-2 | Canine DDX3/DDX3X protein | Canine |
| GM-Tg-bovg-IP6119-Ag-1/ GM-Tg-bovg-IP6119-Ag-2 | Bovine DDX3/DDX3X protein | Bovine |
| GM-Tg-equg-IP6119-Ag-1/ GM-Tg-equg-IP6119-Ag-2 | Equine DDX3/DDX3X protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP6119-Ag-1/ GM-Tg-hg-IP6119-Ag-2;
GM-Tg-rg-IP6119-Ag-1/ GM-Tg-rg-IP6119-Ag-2;
GM-Tg-mg-IP6119-Ag-1/ GM-Tg-mg-IP6119-Ag-2; GM-Tg-cynog-IP6119-Ag-1/ GM-Tg-cynog-IP6119-Ag-2; GM-Tg-felg-IP6119-Ag-1/ GM-Tg-felg-IP6119-Ag-2; GM-Tg-cang-IP6119-Ag-1/ GM-Tg-cang-IP6119-Ag-2; GM-Tg-bovg-IP6119-Ag-1/ GM-Tg-bovg-IP6119-Ag-2; GM-Tg-equg-IP6119-Ag-1/ GM-Tg-equg-IP6119-Ag-2 |
| Products Name | DDX3/DDX3X protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | DDX3/DDX3X |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX3/DDX3X protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.